Q2 FY26 Results: Consolidated revenue up 21 percent, PAT up 19 percent YoY

Revenue Growth 20pctResults RestatedResults View source PDF Explain this filing

SOLARINDS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹13595.00

prior close

₹13615.00

announcement price

In-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.3%-1.9% vs market

Chemicals & Petrochemicals peers, median of 186sector · industry level-0.7%-0.9% vs sector

On the reaction day the stock moved 1.9 pts less than Nifty 100 and 0.9 pts less than its Chemicals & Petrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.6

10m

-0.2

15m

-0.2

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6+0.3-1.9-0.7-0.9

Next day

+1.7+0.7+1.0-1.1+2.8

+3.3+1.4+1.9-0.2+3.6

+1.4+1.4+0.0-0.7+2.1

+2.3+1.5+0.8-1.7+4.0

+2.4+1.9+0.5-1.3+3.7

+1.4+1.9-0.4-2.7+4.2

15d

-2.6+2.2-4.8-5.4+2.8

-8.7+0.4-9.1-7.2-1.5

-4.1+0.8-4.9-11.8+7.7

-1.3+1.6-2.9-11.5+10.2

UpDownMarket · Nifty 100Sector · Chemicals & Petrochemicals peers, median of 186Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated revenue from operations grew 21.4 percent YoY to Rs 2,082.22 cr in Q2 FY26, with H1 FY26 revenue at Rs 4,236.67 cr, up 24.6 percent YoY. Net profit for Q2 was Rs 361.45 cr, up 19 percent YoY, and H1 PAT rose to Rs 714.07 cr. Operating margin dipped marginally to 23.59 percent versus 23.68 percent in Q2 FY25. Previous period figures were restated to reflect final purchase price allocation for the Problast Group acquisition. Board also approved postal ballot to appoint two non-executive directors.

Likely market impact

Strong topline growth with steady profitability. Margin compression is marginal. New director appointments are routine governance.